abstract |
The present disclosure provides methods of treating cancer in a patient, comprising administering to the patient a chemotherapeutic agent, an immunomodulatory agent, and an antisense compound targeted to STAT3. Also provided herein are compositions and kits for performing the methods provided herein. In preferred embodiments, the chemotherapeutic agent is cisplatin, the antisense compound targeted to STAT3 is AZD9150, and the immunomodulatory agent is MEDI4736. |